Literature DB >> 4065759

Clinicopathologic studies on neuro-Behçet's disease.

S Totsuka, T Hattori, M Yazaki, K Nagao, S Mizushima.   

Abstract

Nine cases of neuro-Behcet's disease were investigated clinicopathologically. Pathological pictures of the central nervous system were characterized as follows: the site of predilection was the brain stem, followed by the spinal cord, cerebrum and cerebellum. The pathognomonic changes were recurrent inflammations around small vessels, causing a softening of the tissue. Lesions were composed of a perivascular infiltration of lymphocytes, histiocytes and microglias and, moreover, diapedesis, degenerated nerve cells and oligodendroglias, glial nodule, breakdown of myelin and axon, fatty granule cells and glio-mesenchymal proliferation were present occasionally. Electron microscopic studies on the neurons revealed no evidence of viral particles except for some accumulations of electron dense bodies.

Entities:  

Mesh:

Year:  1985        PMID: 4065759     DOI: 10.1111/j.1440-1819.1985.tb02899.x

Source DB:  PubMed          Journal:  Folia Psychiatr Neurol Jpn        ISSN: 0015-5721


  6 in total

1.  Evaluation of parenchymal neuro-behçet disease by using susceptibility-weighted imaging.

Authors:  S Albayram; S Saip; Z I Hasiloglu; M Teke; E Ceyhan; M Tutuncu; H Selcuk; A Kina; A Siva
Journal:  AJNR Am J Neuroradiol       Date:  2011-04-21       Impact factor: 3.825

2.  Two necropsy cases of chronic encephalomyelitis: variants of Neuro-Behçet's syndrome?

Authors:  E Iseki; K Iwabuchi; S Yagishita; N Amano; M Matsushita
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-08       Impact factor: 10.154

3.  Transient involvement of the cerebral cortex in a flare of Behçet's syndrome.

Authors:  Walter Conca; Soliman A Kamel; Dominic Venne; Peter Corr
Journal:  Rheumatol Int       Date:  2010-01-07       Impact factor: 2.631

4.  Enhanced NLRP3 and DEFA1B Expression During the Active Stage of Parenchymal Neuro-Behçet's Disease.

Authors:  Elif Ugurel; Ece Erdag; Cem Ismail Kucukali; Ayca Olcay; Elif Sanli; Ece Akbayir; Murat Kurtuncu; Tuncay Gunduz; Vuslat Yilmaz; Erdem Tuzun; Burcak Vural
Journal:  In Vivo       Date:  2019 Sep-Oct       Impact factor: 2.155

5.  Gadolinium-enhanced MRI in central nervous system Behçet's disease.

Authors:  E Erdem; R Carlier; A B Idir; P O Masnou; A Moulonguet; D Adams; D Doyon
Journal:  Neuroradiology       Date:  1993       Impact factor: 2.804

6.  Epilepsy associated with systemic autoimmune disorders.

Authors:  Orrin Devinsky; Adam Schein; Souhel Najjar
Journal:  Epilepsy Curr       Date:  2013-03       Impact factor: 7.500

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.